Nanomedicine News

RSS
New Tool to Identify Unstable or High Risk Atherosclerotic Plaques

New Tool to Identify Unstable or High Risk Atherosclerotic Plaques

Providence Introduces Nano-Textured Surface Technology to DTRAX Line of Tissue-Sparing Devices to Enhance Cervical Fusion Process

Providence Introduces Nano-Textured Surface Technology to DTRAX Line of Tissue-Sparing Devices to Enhance Cervical Fusion Process

Computational Modeling Enables Design of Sturdier Liposome

Computational Modeling Enables Design of Sturdier Liposome

ETPN to Help EU Companies Bring Innovative Nanomedicines to Market

ETPN to Help EU Companies Bring Innovative Nanomedicines to Market

NCI Awards Five-Year, $1.8 Million Training Grant for Nanotechnology to Treat Cancer

NCI Awards Five-Year, $1.8 Million Training Grant for Nanotechnology to Treat Cancer

Titan Spine’s FDA-Cleared nanoLOCK Surface Technology Wins Orthopedics This Week’s 2015 Spine Technology Awards

Titan Spine’s FDA-Cleared nanoLOCK Surface Technology Wins Orthopedics This Week’s 2015 Spine Technology Awards

Matinas’ Cochleate Lipid-Crystal Nano-Particle Technology Improves Efficacy of Atovaquone in Treating Pneumocystis Pneumonia

Matinas’ Cochleate Lipid-Crystal Nano-Particle Technology Improves Efficacy of Atovaquone in Treating Pneumocystis Pneumonia

UC Engineering Professor Explores Effective Nanoparticle-Bubble Drug Delivery Systems to Treat Medical Conditions

UC Engineering Professor Explores Effective Nanoparticle-Bubble Drug Delivery Systems to Treat Medical Conditions

Researchers Use Nanoscale Diamonds to Identify Early-Stage Cancerous Tumours

Researchers Use Nanoscale Diamonds to Identify Early-Stage Cancerous Tumours

Ignyta Awarded Patent Covering Composition of Matter of RXDX-107, a New Chemical Entity

Ignyta Awarded Patent Covering Composition of Matter of RXDX-107, a New Chemical Entity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.